Cord blood 25-hydroxyvitamin D3 and allergic disease during infancy

OBJECTIVE: There has been growing interest in vitamin D insufficiency as a predisposing factor for allergy development based on immunoregulatory properties and epidemiological studies. The aim of this study was to investigate the association between vitamin D exposure in utero and allergic outcomes...

Full description

Bibliographic Details
Main Authors: Jones, A., Palmer, D., Zhang, Guicheng, Prescott, S.
Format: Journal Article
Published: 2012
Online Access:http://hdl.handle.net/20.500.11937/9495
_version_ 1848745966487732224
author Jones, A.
Palmer, D.
Zhang, Guicheng
Prescott, S.
author_facet Jones, A.
Palmer, D.
Zhang, Guicheng
Prescott, S.
author_sort Jones, A.
building Curtin Institutional Repository
collection Online Access
description OBJECTIVE: There has been growing interest in vitamin D insufficiency as a predisposing factor for allergy development based on immunoregulatory properties and epidemiological studies. The aim of this study was to investigate the association between vitamin D exposure in utero and allergic outcomes in the first year of life. METHODS: Cord blood (CB) vitamin D was measured in 231 high-risk infants froman Australian prospective birth cohort. CB 25-hydroxyvitamin D3 (25[OH]D3) concentration was analyzed in relation to maternal vitamin D intake and the development of infant eczema, allergen sensitization, and immunoglobulin E-mediated food allergy. RESULTS: Maternal intake of supplemental vitamin D was significantly correlated with CB 25(OH)D3 concentration (r = 0.244, P = .003), whereas dietary vitamin D did not influence CB levels. There was significant seasonal variation in CB 25(OH)D3 concentration suggesting that sunlight exposure was an important determinant. Lower CB vitamin D status was observed in infants that developed eczema (P = .018), and eczema was significantly more likely in those with concentrations <50 nmol/L in comparison with those with concentrations =75 nmol/L (odds ratio 2.66; 95% confidence interval 1.24-5.72; P = .012). This association remained significant after adjustment for multiple confounding factors. The associations between CB 25(OH)D3 concentration and allergen sensitization, immunoglobulin E-mediated food allergy, and eczema severity (SCORing Atopic Dermatitis) were not significant. CONCLUSIONS: Reduced vitamin D status in pregnancy may be a risk factor for the development of eczema in the fi rst year of life, reinforcing the need to explore the role of vitamin D exposure during development for disease prevention. Copyright © 2012 by the American Academy of Pediatrics.
first_indexed 2025-11-14T06:25:45Z
format Journal Article
id curtin-20.500.11937-9495
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T06:25:45Z
publishDate 2012
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-94952017-09-13T14:52:44Z Cord blood 25-hydroxyvitamin D3 and allergic disease during infancy Jones, A. Palmer, D. Zhang, Guicheng Prescott, S. OBJECTIVE: There has been growing interest in vitamin D insufficiency as a predisposing factor for allergy development based on immunoregulatory properties and epidemiological studies. The aim of this study was to investigate the association between vitamin D exposure in utero and allergic outcomes in the first year of life. METHODS: Cord blood (CB) vitamin D was measured in 231 high-risk infants froman Australian prospective birth cohort. CB 25-hydroxyvitamin D3 (25[OH]D3) concentration was analyzed in relation to maternal vitamin D intake and the development of infant eczema, allergen sensitization, and immunoglobulin E-mediated food allergy. RESULTS: Maternal intake of supplemental vitamin D was significantly correlated with CB 25(OH)D3 concentration (r = 0.244, P = .003), whereas dietary vitamin D did not influence CB levels. There was significant seasonal variation in CB 25(OH)D3 concentration suggesting that sunlight exposure was an important determinant. Lower CB vitamin D status was observed in infants that developed eczema (P = .018), and eczema was significantly more likely in those with concentrations <50 nmol/L in comparison with those with concentrations =75 nmol/L (odds ratio 2.66; 95% confidence interval 1.24-5.72; P = .012). This association remained significant after adjustment for multiple confounding factors. The associations between CB 25(OH)D3 concentration and allergen sensitization, immunoglobulin E-mediated food allergy, and eczema severity (SCORing Atopic Dermatitis) were not significant. CONCLUSIONS: Reduced vitamin D status in pregnancy may be a risk factor for the development of eczema in the fi rst year of life, reinforcing the need to explore the role of vitamin D exposure during development for disease prevention. Copyright © 2012 by the American Academy of Pediatrics. 2012 Journal Article http://hdl.handle.net/20.500.11937/9495 10.1542/peds.2012-1172 unknown
spellingShingle Jones, A.
Palmer, D.
Zhang, Guicheng
Prescott, S.
Cord blood 25-hydroxyvitamin D3 and allergic disease during infancy
title Cord blood 25-hydroxyvitamin D3 and allergic disease during infancy
title_full Cord blood 25-hydroxyvitamin D3 and allergic disease during infancy
title_fullStr Cord blood 25-hydroxyvitamin D3 and allergic disease during infancy
title_full_unstemmed Cord blood 25-hydroxyvitamin D3 and allergic disease during infancy
title_short Cord blood 25-hydroxyvitamin D3 and allergic disease during infancy
title_sort cord blood 25-hydroxyvitamin d3 and allergic disease during infancy
url http://hdl.handle.net/20.500.11937/9495